P3 Health Partners Inc (PIII)
0.5396
-0.02
(-2.77%)
USD |
NASDAQ |
Jun 26, 13:24
P3 Health Partners Cash from Financing (Quarterly): 11.40M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 11.40M |
| December 31, 2023 | -0.84M |
| September 30, 2023 | -0.086M |
| June 30, 2023 | 87.16M |
| March 31, 2023 | 14.10M |
| December 31, 2022 | 15.00M |
| Date | Value |
|---|---|
| September 30, 2022 | -1.179M |
| June 30, 2022 | -1.239M |
| March 31, 2022 | -1.207M |
| September 30, 2021 | -0.0226M |
| June 30, 2021 | 12.54M |
| March 31, 2021 | -0.0222M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.239M
Minimum
Jun 2022
87.16M
Maximum
Jun 2023
11.30M
Average
-0.0224M
Median
Cash from Financing (Quarterly) Benchmarks
| American Shared Hospital Services | 2.282M |
| Novo Integrated Sciences Inc | 0.0032M |
| Astrana Health Inc | 106.35M |
| Cryo-Cell International Inc | 0.539M |
| Biote Corp | -5.409M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -20.03M |
| Free Cash Flow | -72.34M |
| Free Cash Flow Per Share (Quarterly) | -0.1685 |
| Free Cash Flow to Equity (Quarterly) | -31.28M |
| Free Cash Flow to Firm (Quarterly) | -15.59M |
| Free Cash Flow Yield | -62.92% |